Introduction
several thousand-fold (Dayton et al., 1986; Fisher et al., 1986; Huang et al., 1994) . This defect has been attributed Reverse transcription is a process used by retroviruses to the critical role that Tat plays in activating HIV-1 gene in which the combined activities of the virus-encoded expression (Kao et al., 1987; Berkhout et al., 1989 ; Laspia heterodimeric reverse transcriptase results in the synthesis et Feinberg et al., 1991 ; Marciniak and of proviral DNA from its RNA genome (Baltimore, 1970; Sharp, 1991; Kato et al., 1992) . Tat activation is dependent Temin and Mitzutani, 1970) . Reverse transcription is upon a stable RNA stem-loop structure, that extends from initiated by reverse transcriptase which, in conjunction the transcription initiation site to ϩ57, known as TAR with a cell-derived tRNA, binds to retroviral RNA (Rosen et al., 1985; Muesing et al., 1987 ; Feng and sequences known as the primer binding site (PBS) (Panet et al., 1975) . The binding of tRNA to the PBS in Holland, 1988; Garcia et al., 1989; Selby et al., 1989) which serves as the binding site for Tat (Dingwall et al., to regulating transcriptional activation (Huang et al., 1994) . More specifically, although other viral transactiv-1990) . Tat, in conjunction with TAR RNA, results in marked stimulation of the elongation properties of RNA ators could fully complement the transcriptional defects of viruses mutated in their tat genes, these viruses were polymerase II (Kao et al., 1987; Laspia et al., 1989 Laspia et al., , 1990 Feinberg et al., 1991; Marciniak and Sharp, 1991 ; Kato unable to replicate efficiently or cause cytopathicity (Huang et al., 1994 (Huang et al., ). et al., 1992 and these effects are probably mediated by association of Tat with RNA polymerase II or other An HIV-1 provirus was constructed which contained a deletion in the tat gene such that only the first five amino components of the HIV-1 transcriptional elongation complex (Keen et al., 1996; Mavankal et al., 1996) . Alterations acids could be expressed. This virus produced only low levels of gene expression (Ͻ10 pg/ml of p24 antigen) in TAR RNA structure markedly decrease Tat activation, and viruses containing these TAR RNA mutations exhibit following transfection of a variety of different cell lines, indicating the lack of a functional Tat protein.
In an several thousand-fold decreases in replication upon infection of peripheral blood mononuclear cells (PBMCs) or attempt to isolate sufficient amounts of the virus for further studies, the puromycin resistance gene was inserted in T-cell lines (Harrich et al., 1994 (Harrich et al., , 1995 (Harrich et al., , 1996 Klaver and Berkhout, 1994) . TAR revertant viruses arising from the place of nef, and stable cell lines containing tat-deleted viruses were isolated (Morgenstern and Land, 1990) . A original HIV-1 TAR mutant viruses were isolated and exhibited nearly wild-type levels of gene expression due variety of T-lymphocyte cell lines were used, but only low levels of HIV-1 gene expression were obtained. to partial restoration of TAR RNA stem base pairing and their ability to bind Tat (Harrich et al., 1995) . However, However, 293 cells which contain the adenovirus E1A and E1B proteins are able to strongly activate HIV-1 gene subtle base pair changes that alter TAR RNA structure were still present in these revertant viruses and they were expression and complement the defect in gene expression in viruses lacking tat (Graham et al., 1977; Kliewer et al., found to be defective for reverse transcription following infection of PBMCs (Harrich et al., 1996) . Analysis of 1989; Harrich et al., 1994 Harrich et al., , 1995 Harrich et al., , 1996 . Using puromycin selection of 293 cells transfected with HIV-1 deleted in the original HIV-1 TAR mutant viruses further demonstrated that an intact TAR element was required for efficient their tat gene, we were able to obtain clonal 293 cell lines producing virus lacking the tat gene. We routinely obtained reverse transcription (Harrich et al., 1996) . Whether the effect of TAR on modulating the efficiency of reverse viral supernatant which contained 1-2 ng/ml of p24 antigen after 16 h of cell culture. These 293 isolates were transcription was mediated entirely by RNA secondary structure or by the binding of cellular or viral factors expanded and analyzed using PCR to confirm the presence of intact 5Ј and 3Ј long terminal repeats (LTRs) and a remains unclear.
Given the fact that TAR is critical for both the regulation defective tat gene. The 293 cells containing the tat-defective provirus of HIV-1 gene expression and reverse transcription, we wished to investigate whether the Tat protein was also designated Δtat were expanded and transfected with either an RSV expression vector lacking the tat gene or a similar involved in regulating both of these processes. Using HIV-1 deleted in the tat gene, we were able to demonstrate expression vector containing the wild-type tat gene (Garcia et al., 1988) . HIV-1 supernatants containing similar that virions that lacked Tat were unable to undergo efficient reverse transcription either following infection of PBMCs amounts of reverse transcriptase activity were obtained from 293 cell lines producing either wild-type, Δtat or or in endogenous reverse transcription assays. However, transfection of tat expression vectors into cell lines producΔtat virus complemented with wild-type tat. A further biochemical characterization of these viruses was pering viruses deleted in the tat gene resulted in the generation of viruses that were able to undergo efficient reverse formed in Figures 3 and 4 (see below). These viruses were used to infect PBMCs, and the ability of these transcription upon infection of PBMCs or in endogenous reverse transcription assays. No difference in the levels viruses to undergo reverse transcription was assayed by PCR analysis of low molecular weight DNA obtained at 2 of reverse transcriptase, genomic RNA or other proteins incorporated into virions lacking tat were detected as and 24 h post-infection (Hirt, 1967) . Reverse transcription products corresponding to (-) strong stop ( Figure 1A ), compared with wild-type HIV-1. These studies demonstrate that the Tat protein either directly or indirectly is jump ( Figure 1B ) and full-length ( Figure 1C ) DNA were analyzed as described (Zack et al., 1990) . As shown in able to modify virion particles, to increase their ability to undergo efficient HIV-1 reverse transcription. Figure 1 , the Δtat virus was very defective in reverse transcription at both 2 and 24 h post-infection, as reflected in the low amounts of (-) strong stop DNA ( Figure 1A -
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C, lanes 9 and 14) compared with that seen with wildtype HIV-1 ( Figure 1A -C, lanes 7 and 12). Transfection Tat is required for efficient HIV-1 reverse transcription of an expression vector encoding tat onto 293 cells producing wild-type HIV-1 did not alter the ability of this Since we demonstrated that the HIV-1 TAR RNA was required for efficient reverse transcription (Harrich et al., virus to undergo reverse transcription upon subsequent infection of PBMCs ( Figure 1A -C, lanes 8 and 13) as 1996), we next addressed whether this process may be modulated by the Tat protein. TAR is necessary for compared with wild-type HIV-1 alone ( Figure 1A -C, lanes 7 and 12). In contrast, transfection of the tat expression mediating Tat activation of HIV-1 gene expression (Rosen et al., 1985; Muesing et al., 1987; Feng and Holland, vector onto 293 cells producing the Δtat virus resulted in virus that synthesized increased amounts of (-) strong 1988; Garcia et al., 1989; Selby et al., 1989; Dingwall et al., 1990) , and a previous study suggested that Tat may stop DNA upon subsequent infection of PBMCs ( Figure  1A , lanes 10 and 15). Similar increases in the levels of function at other points in the HIV-1 life cycle in addition . At 2 h post-infection, residual virus was removed by washing and Hirt lysates were prepared from half of the infected cells while the remaining PBMCs were cultured for 24 h and Hirt lysates were prepared. The recovered nucleic acids were assayed for HIV-1 (-) strong stop (A, lanes 1-15), the first strand jump (B, lanes 1-15) and full-length DNA (C, lanes 1-15). Quantitative PCR analysis of cyt-oxy II content in Hirt lysates was used to standardize the DNA recovery (D, lanes 1-15). All PCR reactions were performed within the linear range as determined by assays of HIV-1 DNA copy number (0, 10, 50, 250 and 1000) or cell number (0, 2ϫ10 2 , 2ϫ10 3 , 1ϫ10 4 and 5ϫ10 4 ). This analysis is representative of PCR reactions performed on three separate HIV-1 infections using independently prepared virus stocks. the reverse transcription products were seen with the Δtat virus produced following transfection with wild-type tat by analyzing jump DNA at 2 ( Figure 1B , lane 10) and 24 h ( Figure 1B , lane 15) and full-length DNA at 24 h ( Figure 1C, lane 15) . Analysis of the magnitude of the defects in Δtat virus reverse transcription relative to wildtype HIV-1 was analyzed by Phosphorimager quantitation at 24 h post-infection and indicated that the Δtat virus exhibited a 10-fold defect in strong stop DNA, a 7-fold defect in jump DNA and a 30-fold defect in full-length DNA. These defects were not detected in virus produced following transfection of the wild-type tat gene into 293 cells containing the Δtat virus. No reverse transcription products were detected in infections performed using recovery ( Figure 1D, lanes 1-15) . These results indicate that the tat gene is involved in the ability of HIV-1 to undergo efficient reverse transcription.
Δtat virus produced following transfection with wild-type tat were again used to infect PBMCs (Figure 2 (Figure 2 ). In contrast, wild-type HIV-1 gave high levels of p24 antigen expression (Figure 2 ). These results indicate that although wild-type tat can complement the defect in reverse transcription seen with the Δtat virus both before and after transfection of the wild-type tat gene to determine whether decreased synthesis of HIV-1 proteins may account for the defects noted in reverse transcription upon infection of PBMCs. To compare the similar with these different viruses with a ratio of reverse transcriptase/p24 ranging from~3.2 to 2.6. Next, these biochemical properties of these viruses, filtered viral supernatant from 293 cells was harvested by centrifugation viruses were analyzed by Western blot analysis using human IgG antibodies directed against HIV-1 or a monoand analyzed for both reverse transcriptase activity and p24 antigen ( Figure 3A ). This analysis indicated that the clonal antibody directed against gp120. This analysis indicated that the amount of gp120 and other HIV-1 reverse transcriptase activity and p24 antigen levels were proteins were similar for wild-type HIV-1, Δtat virus and Δtat virus produced following transfection of 293 cells with the wild-type tat expression vector ( Figure 3B ).
Finally, we determined whether the same amount of HIV-1 RNA was incorporated into the wild-type and Δtat virions produced in either the presence or absence of a wild-type tat gene transfected into 293 cells. Virus preparations containing equal amounts of p24 antigen were subjected to PCR analysis. Similar amounts of RNA were incorporated into HIV-1 wild-type ( Figure 4A , lanes 3 and 4), Δtat virus ( Figure 4A , lanes 5 and 6) and Δtat virus produced following transfection with wild-type tat ( Figure 4A , lanes 7 and 8). There was no RNA detected in mock-infected 293 supernatants ( Figure 4A , lanes 1 and 2) and the amount of an internal control HIV-1 RNA included in each sample prior to PCR analysis was similar ( Figure 4B , lanes 1-8). Thus no gross biochemical abnormalities were detectable in the tat mutant virus as compared with wild-type HIV-1. . Analysis of these PCR assays using Phosphorimager quantitation indicated that duced from the 293 cells containing wild-type HIV-1, Δtat virus or Δtat virus complemented with wild-type tat. The relative to wild-type HIV-1 there were defects in strong stop, jump and full-length products of 8-, 10-and 30-fold levels of HIV-1 reverse transcription products were assayed at 24 h post-infection. for Δtat virus alone; 12, 16-and 100-fold for Δtat virus complemented with tat/cys; 5-, 6-and 50-fold for Δtat
No reverse transcription products were detected with any of the viruses when they were used to infect HeLa virus complemented with Δ53 and of 2-fold or less for Δtat virus complemented with Δ60. There were no cells lacking the CD4 receptor ( Figure 7A -C, lanes 5-7). In contrast, reverse transcription products were detected detectable PCR products following mock infection of PBMCs ( Figure 6A -C, lane 1) and there was equal when 293 supernatants containing either the wild-type, Δtat virus or the Δtat virus complemented with wild-type recovery of DNA from the PBMCs as judged by equivalent PCR products seen with the control cyt-ox II ( Figure 6D , tat were used to infect HeLa CD4 cells (Figures 7A-C, lanes 12-14). The Δtat virus was very defective in the lanes 1-7). These results indicate that the ability of tat to complement reverse transcription of the Δtat virus was synthesis of reverse transcription products when used to infect HeLa CD4 cells ( viruses produced in 293 cells was used to infect HeLa deoxynucleotides (dNTPs) ( Figure 8A , lanes 2, 4, 6, 8, 10 and 12) or dNTPs lacking dTTP ( Figure 8B , lanes 2, CD4 cells containing the tat gene, the Δtat virus was again very defective for reverse transcription, with defects 4, 6, 8, 10 and 12). The dTTP was omitted from these reactions to demonstrate that the DNA detected by PCR ranging from 20-fold for strong stop and jump DNA to 100-fold for full-length DNA ( Figure 7A-C, lane 20) . In was the product of the endogenous reverse transcription reaction rather than pre-existing endogenous DNA. These contrast, the Δtat virus complemented with wild-type tat ( Figure 7A -C, lane 21) and wild-type HIV-1 ( Figure 7A virions were incubated in a stop solution (10 mM Tris pH 8.0, 10 mM EDTA, 20 μg/ml herring sperm DNA and C, lane 19) gave similar levels of reverse transcription products. Neither mock infection or heat-treated viruses 50 μg/ml proteinase K) at 50°C then at 95°C for 10 min and assayed by PCR for the presence of HIV-1 (-) strong gave detectable levels of reverse transcription products when used to infect any of the HeLa cell lines (Figure stop DNA. The amount of (-) strong stop DNA synthesized in the endogenous reverse transcription assay was similar 7A-C, lanes 1-4; lanes 8-11; lanes 15-18). There was equal recovery of DNA samples from the HIV-1-infected for wild-type HIV-1 ( Figure 8A , lane 2), Δtat virus produced following transfection of 293 cells with wildHeLa cells as determined from PCR analysis of the cytoxy II gene ( Figure 7D, lanes 1-21) . These results indicate type tat ( Figure 8A , lane 6) and Δtat virus produced following transfection with the Δ60 tat mutant (Figure  that the expression of wild-type tat in the producer cells but not the target cells was able to reverse the defects in 8A, lane 12). In contrast, there was a marked decrease in the amount of (-) strong stop DNA synthesized with the reverse transcription seen with the Δtat virus.
Δtat virus ( Figure 8A , lane 4) or the Δtat virus produced following transfection of 293 cells with either the tat/cys HIV-1 virions lacking tat exhibit defects in endogenous reverse transcription mutant ( Figure 8A , lane 8) or the tat mutant Δ53 ( Figure  8A , lane 10). Phosphorimager quantitation of the PCR Finally, we assayed endogenous reverse transcription (Arts et al., 1994) using virions produced in 293 cell lines assays indicated that Δtat virus exhibited a 10-fold defect relative to wild-type HIV-1. The Δtat virus produced expressing either wild-type HIV-1, Δtat virus or Δtat virus complemented following transfection with wild-type tat following transfection of 293 cells with wild-type tat was 2-fold higher than wild-type virus, while the Δtat virus or different tat mutants. Virus stocks containing equal quantities of reverse transcriptase were treated with DNase produced following transfection of 293 cells with tat/ cys exhibited a 16-fold defect, the Δtat virus produced I to remove potential contaminating chromosomal DNA. PCR analysis was then performed on a portion of these following transfection with Δ53 tat exhibited a 5-fold defect and the Δtat virus produced following transfection virions with specific primers to detect pre-existing endogenous DNA ( Figure 8A and B, lanes 1, 3, 5, 7, 9 and with Δ60 tat exhibited no defect. DNase I treatment was sufficient to remove potential contaminating chromosomal 11). The other portion of the virions was incubated for 60 min at 37°C in the presence of either 12 μM DNA or cell nuclei as indicated by the near complete degradation of 10 6 copies of an HIV-1 plasmid containing into the 293 cells containing the Δtat virus. These studies indicate the requirement for a functional Tat protein to DNA sequences detected by PCR that was added to viral supernatant not supplemented with dNTPs ( Figure 8A , complement the defects seen with virions lacking tat. However, the defect in reverse transcription of the Δtat lane 13). No HIV-1 DNA was detected in DNase I-treated wild-type HIV-1 supernatant not supplied with dNTPs virus upon infection of PBMCs was not due to detectable differences in the amount of HIV-1 proteins such as ( Figure 8B, lane 14) . Finally, there was little synthesis of (-) strong stop DNA when dTTP was omitted from the gp120. Furthermore, the amount of p24 antigen, reverse transcriptase and intravirion RNA was standardized careendogenous reaction ( Figure 8B, lanes 2, 4, 6, 8, 10 and 12), indicating that virions required exogenous pools of fully for each of the viral stocks produced from the 293 cell lines so that any potential differences between the deoxynucleotides to initiate measurable levels of (-) strong stop DNA. These results indicate that the levels of stocks could be identified. The Δtat virus produced in 293 cells complemented with wild-type but not mutant tat endogenous reverse transcription for the wild-type and Δtat-deleted viruses correlated with the in vivo reverse genes can undergo efficient reverse transcription both in vivo and in vitro in the presence of an exogenous dNTP transcription analysis for these viruses. pool. Although it is possible that subtle changes in HIV-1 virion structure occur in the absence of tat, electron Discussion microscopy did not detect ultrastructural abnormalities of viruses lacking tat which were produced under conditions Recently, we demonstrated that a number of HIV-1 mutants in TAR were defective for reverse transcription upon where their gene expression was complemented with heterologous viral transactivators (Huang et al., 1994) . infection of PBMCs (Harrich et al., 1996) . Since TAR RNA is involved in the control of HIV-1 reverse transcrip-A variety of studies indicate that reverse transcription is subject to complex regulation by both viral and cellular tion, we investigated whether the tat gene which requires TAR RNA to activate gene expression might also be proteins. For example, the cellular milieu is critical for the efficiency of HIV-1 reverse transcription as reflected required for efficient reverse transcription. Previous data have demonstrated that HIV-1 virions containing deletions in the marked defects in replication seen in quiescent lymphocytes (Zack et al., 1990 (Zack et al., , 1992 ; O'Brian et al., in the tat gene were very defective for viral replication (Dayton et al., 1986; Fisher et al., 1986; Huang et al., 1994) . Mutants in several viral proteins including integrase (Masuda et al., 1995) , Nef (Schwartz et al., 1995) and . This defect has been attributed primarily to a failure of tat-mediated increases in HIV-1 gene expression Vif (von Schwedler et al., 1993) result in viruses that exhibit defects in reverse transcription. In addition, the (Dayton et al., 1986; Fisher et al., 1986) . However, the fact that heterologous viral transactivators inserted into nucleocapsid which facilitates strand transfer may also increase the efficiency of reverse transcription (Lapadat-HIV-1 proviruses lacking tat could complement defects in HIV-1 gene expression but not defects in viral replication Tapolsky et al., 1993 Tapolsky et al., , 1995 Allain et al., 1994; Peliska et al., 1994) . Cellular proteins including DNA topoisomerand cytopathicity suggested potential effects of tat in regulating other steps in the viral life cycle (Huang ase I (Priel et al., 1990 ) and cyclophilin A (Franke et al., 1994; Thali et al., 1994) are also present in HIV-1 virions. et al., 1994) .
A role for tat in early steps in the HIV-1 life cycle has DNA topoisomerase I has been suggested to stimulate the elongation properties of reverse transcriptase (Priel et al. , not been demonstrated due at least in part to difficulty with obtaining sufficient quantities of HIV-1 virions lacking tat.
1990; Jardine et al., 1993; Takahashi et al., 1995) . Cyclophilin A is incorporated into the HIV-1 particle via its The adenovirus E1A and E1B proteins in the 293 cells (Graham et al., 1977) complement the defects in HIV-1 interactions with the Gag protein (Franke et al., 1994; Thali et al., 1994) . Mutations in critical proline residues gene expression seen with both TAR and tat mutants because the primary effect of E1A on activating gene in Gag which bind cyclophilin A result in virions which exhibit defects in replication that may be due in part to expression is by interaction with upstream cellular transcription factors (Kliewer et al., 1989) . Clonal populations defects in reverse transcription (Braaten et al., 1996) . These results suggest that HIV-1 reverse transcription is of 293 cells containing HIV-1 deleted in the tat gene were isolated and the quantity of this virus was sufficient to subject to complex regulation and that viral and cellular proteins in addition to reverse transcriptase are probably analyze early steps in the HIV-1 life cycle. Surprisingly, we found that HIV-1 lacking the tat gene was very critical in regulating the efficiency of this process. Recent studies suggest that reverse transcription may defective in the initiation of reverse transcription as reflected in defects in the synthesis of (-) strong stop have at least three defined stages of regulation, including initiation, a transition between initiation and elongation, DNA. There was a corresponding decrease in the amount of first strand synthesis and a further defect in the synthesis and elongation (Isel et al., 1996) . This pattern of regulation is dependent on modified nucleosides in the tRNA 3 Lys of full-length DNA, suggesting that the processivity of the reverse transcriptase might also be affected in virus which facilitate interactions with the HIV-1 PBS and with an A-rich loop located 12-17 nucleotides upstream of the lacking tat. It will be important to determine whether the defects in reverse transcription seen with virus lacking tat PBS (Isel et al., , 1996 . This complex pattern of RNA interactions may be critical for the regulation of the are entirely due to a defect in initiation or whether additional effects of reverse transcriptase processivity are transition between the initiation and elongation of reverse transcription which is seen with HIV-1 reverse tranalso present.
The defects in reverse transcription seen with HIV-1 scriptase but not with several other viral reverse transcriptases (Arts et al., 1996b) . Data indicating that lacking tat could be prevented by transfection of wildtype but not a variety of mutant tat expression vectors tRNA 3 Lys DNA chimeras can lead to the synthesis of (-) transcription process (Arts et al., 1996a) . Our previous Both the wild-type and mutant eucaryotic vectors expressing tat were finding that TAR RNA is involved in the regulation of described previously (Garcia et al., 1988) . For these vectors, the HIV-1 (-) strong stop DNA synthesis would be consistent with tat gene encoding either the first 72 amino acids (wild-type), 60 amino a role for TAR RNA in these multiple RNA interactions acids (Δ60), 53 amino acids (Δ53) or serine substitutions of cysteine at residues 22, 27, 31 and 34 (tat/cys) were placed downstream of the to regulate an early step in the synthesis of (-) strand RSV promoter in a vector containing the SV40 splice acceptor and strong stop DNA synthesis.
polyadenylation sequences (Garcia et al., 1988) .
The question arises as to how tat is able to stimulate efficient reverse transcription. One possibility is that tat
Cells and cell lines
is incorporated into HIV-1 virion particles via binding to A 100 mm plate of 50% confluent 293 cells (Graham et al., 1977) was transfected with 20 μg of MroI-linearized pBRDH2puro-Δtat (Harrich TAR RNA (Dingwall et al., 1990; Calnan et al., 1991; . The transfected 293 cells were split 1:25, 3 days post- Weeks and Crothers, 1991) . Tat binding to TAR RNA transfection and grown in modified Iscove's medium supplemented with may alter TAR structure such that the initiation of reverse 5% newborn calf serum (NCS), 2.5% fetal bovine serum (FBS), 1% transcription is enhanced. For example, NMR analysis penicillin-streptomycin and 1 μg/ml puromycin. In 4-6 weeks, individual cell foci were removed from the culture dish using cloning wells (Bellco, indicated that Tat binding induces a conformational change directed against Tat, we have been unable to detect Tat PBMCs were obtained from HIV-1 seronegative donors and grown in protein in concentrated preparations of HIV-1 virus. This RPMI supplemented with 20% FBS (Gibco-BRL), 1% penicillincould be due to the fact that the detection limits of our streptomycin (Gibco-BRL) and 5 μg/ml phytohemagglutinin (Boehringer Western blot analysis using polyclonal Tat antibodies fail Mannheim) for 3 days (Harrich et al., 1994) . The PBMCs were then placed in RPMI culture medium supplemented with 20 U/ml interleukin-2 reproducibly to detect Tat if only four or less molecules (BTI, Inc.) and used immediately for HIV-1 infection experiments.
are present in each virion particle. Alternatively, Tat could have an indirect effect on
Virus stocks
stimulating reverse transcription by altering either virion All HIV-1 virus stocks including wild-type and Δtat mutants were structure or the association of viral or cellular factors. For produced in stable 293 cell lines (Graham et al., 1977; Harrich et al., 1994 Harrich et al., , 1996 . The 293 cell lines were grown in 100 mm dishes until they example, Tat could alter intravirion nucleotide pools which were 75% confluent and the culture medium was replaced with RPMI are critical for efficient reverse transcription (Zack et al., 1640 supplemented with 10% FBS, 1% penicillin-streptomycin and 1% 1990 O'Brian et al., 1994) . However, our analysis glutamine (Gibco-BRL) and cultured for 16 h. To complement 293 5250 using sensitive techniques (Sherman and Fyfe, 1989 ) did cells with either wild-type or mutant tat genes, 100 mm plates of 40% confluency were transfected using lipofectamine with 5 μg of expression not demonstrate differences in the nucleotide levels in Further studies will be required to elucidate the mechanism FBS, 1% penicillin-streptomycin and 1% glutamine (Gibco-BRL) and by which Tat enhances the efficiency of HIV-1 reverse cultured for 16 h. All virus supernatants were collected, passed through a 0.45 μm filter and stored in aliquots at -80°C. All virus stocks were transcription. Such studies could potentially identify novel assayed for p24 antigen by ELISA and reverse transcriptase activity transdominant inhibitors as well as yield a better underusing a non-radioactive assay that utilized a synthetic template-primer standing of potential cellular and viral factors that regulate hybrid poly(A)-oligo(dT) 15 and digoxigenin-biotin-labeled dUTP, which this key step in the HIV-1 life cycle.
was detected by an ELISA protocol (Boehringer Mannheim) when incorporated into the newly synthesized DNA.
Immunoblot analysis of virions

Materials and methods
Virus stocks were pelleted by centrifugation at 22 000 g for 2 h at 4°C and suspended in phosphate-buffered saline/1% bovine serum albumin Plasmids The HIV-1 proviral construct pBRDH2puro was made by inserting the (PBS/BSA). The virus suspensions were assayed for reverse transcriptase activity and p24 antigen content. Each virus suspension was diluted and puromycin resistance gene (Morgenstern and Land, 1990 ) into the proviral construct pBRDH1 which was derived from HIV-1 pBH10 normalized to 0.35 ng of p24 antigen/μl in 4ϫ Laemmli buffer. Viral lysates were incubated at 95°C for 10 min and 25 ng of p24 antigen (Hahn et al., 1984) . The tat deletion construct pBRDH2puro-Δtat was derived from pBRDH2puro that was linearized with the restriction was loaded in each lane. Samples were subjected to electrophoresis on 10% SDS-polyacrylamide gels. The proteins were transferred to enzyme BanII and treated with mung bean nuclease. The digested plasmid was incubated with T7 polymerase in the presence of deoxynitrocellulose and probed with either 1:10 000 human anti-HIV-1 IgG (NIH ARRP #192) or 1:1000 dilution of IgG-purified rabbit anti-gp120 of 10 μl of each of the endogenous reverse transcription reactions were performed for (-) strong stop DNA using 'hot' PCR as described, except (Intracel). Secondary antibodies were horseradish peroxidase (HRP)-coupled sheep anti-human at 1:5000 or HRP-coupled goat anti-rabbit for the addition of 2 mM MgCl 2 . at 1:3000. Visualization of proteins was carried out using enhanced chemiluminescence (Amersham).
PCR analysis of HIV-1 DNA Chromosomal DNA from 293 cell lines expressing either the wild-type or tat mutant HIV-1 virus was isolated as previously described (Hirt, HIV-1 infection The HIV-1 wild-type and tat mutants were normalized for reverse 1967; Harrich et al., 1996) . The 5Ј and 3Ј LTRs and the tat gene from the 293 cell lines stably expressing the Δtat mutant virus were obtained transcriptase activity. Typically, HIV-1 supernatant containing reverse transcriptase activity equal to 6 ng (5 U/μg) of recombinant reverse by PCR. Optimized PCR reagents were obtained from Invitrogen and Taq DNA polymerase was purchased from Boehringer Mannheim. transcriptase was supplemented with 10 mM MgCl 2 and 300 U of DNase I (Worthington Biochemical, New Jersey) and then incubated at 30°C
Exactly 200 ng of purified chromosomal DNA and 50 ng of the oligonucleotide pairs (-436/-415) (5Ј-CCCAAACAAGACAAGAGATfor 30 min. DNase I-treated viral supernatant was heat inactivated at 60°C for 20 min for use in control infections. For each infection, 2ϫ10 7 TGA -3Ј, sense) and (ϩ242/ϩ219) (5Ј-CCTGCGTCGAGAGAGCTCC-TCTGG-3Ј, antisense) (5Ј LTR); (ϩ8605/ϩ8625) (5Ј-GCAGCTTTAactivated PBMCs were infected with the appropriate DNase I-treated virus stock in a 150 mm tissue culture plate with gentle reciprocal GATATTAGCCAC-3Ј, sense) and (ϩ9282/ϩ9258) (5Ј-CTGCTAGA-GATTTTTCCACACTGAC-3Ј, antisense) (3Ј LTR); (ϩ5417/ϩ5446) shaking at 37°C for 2 h. The heat-inactivated virus stocks were used to infect 1ϫ10 7 activated PBMCs in 100 mm tissue culture plates. Cells (5Ј-GCCATAATAAGAATTCTGCAACAACTGCTG-3Ј, sense) and (ϩ5653/ϩ5634) (5Ј-GGTTGCATTACATGTACTAC-3Ј, antisense) (tat used in the infection were washed three times with RPMI 1640 supplemented with 10% FBS, 1% penicillin-streptomycin and 1% gene) were subjected to 40 cycles of PCR at 95, 55 and 72°C for 1 min at each temperature using 1.25 U of Taq DNA polymerase (Zack et al., glutamine (Gibco-BRL) . All cells infected with heat-inactivated virus or one half of the infected cells were removed and total cytoplasmic nucleic 1990). The expected 678, 677 and 237 bp DNA products, respectively for the 5Ј LTR, 3Ј LTR and the tat gene were resolved and purified from acids were obtained by modified Hirt lysis. Briefly, the cell pellet was washed in 1ϫ phosphate-buffered saline, pelleted at 400 g for 10 min, a 6% polyacrylamide gel. The DNA fragments were ligated into TA vector (Invitrogen) and analyzed by DNA sequencing. and gently resuspended in 0.5 ml of Tris buffer (10 mM Tris pH. 7.0, 10 mM EDTA). The cell suspension was vortexed gently and lysis Nucleic acids concentrations of Hirt lysates were normalized by 'hot' PCR amplification targeted to the mitochondrial DNA-encoded cyt-oxy solution was added (10 mM Tris pH 7.0, 10 mM EDTA, 1.2% SDS and 2 mg/ml proteinase K), then incubated at 37°C for 2 h. Exactly 0.25 ml II gene. Hirt lysates were serially diluted in 5-fold increments and 5 μl of each dilution was assayed by 'hot' PCR. Taq DNA polymerase was of 5.0 M NaCl was added to each lysate and left on ice overnight. Each lysate was subjected to centrifugation at 15 000 g for 1 h. The supernatant first inactivated with Taqstart Ab (Clontech) for 5 min at room temperature, then added to a master PCR mix that contained 1ϫ optimized buffer was decanted and phenol:chloroform:isoamyl alcohol (25:24:1) solution was added, vigorously vortexed, and centrifuged at 15 000 g for 15 min. D (Invitrogen), 0.1 mM dNTPs, 50 ng of an unlabeled oligonucleotide (5Ј-CACATGCAGCGCAAGTAGGT-3Ј, sense) and 25 ng of a 32 P endThe aqueous layer was transferred to a fresh tube and the nucleic acids were precipitated with two volumes of ethanol overnight at -20°C. The labeled oligonucleotide (Ͼ5ϫ10 8 c.p.m./μg) (5Ј-GGAAATGATTATG-AGGGCGTG-3Ј, antisense) which hybridized to the human cyt-oxy II nucleic acids were pelleted by centrifugation at 15 000 g at 4°C for 1 h and the alcohol was carefully removed, leaving a visible pellet that was gene. After a 95°C denaturation for 5 min, 20-23 cycles of amplification were performed at 93°C for 1 min and 65°C for 2 min. The PCR washed with cold 70.0% ethanol, air dried, and resuspended in 50.0 ml of PCR quality TE (10 mM Tris pH 7.8, 0.1 mM EDTA). The remaining products were separated by electrophoresis on a 6% polyacrylamide gel. The dried gels were quantified on a Molecular Dynamics PhosphoImager cells were cultured for an additional 22 h then processed by modified Hirt lysis.
and visualized by autoradiography. Generally, the PCR of the cyt-oxy II mitochondrial gene produced linear amplification in the 10 2 -10 4 dilution To determine viral replication kinetics, 2ϫ10 6 activated PBMCs were infected with either HIV-1 wild-type or tat mutant viral supernatants of the original Hirt lysates. The concentrations of the Hirt lysate nucleic acids were normalized for cyt-oxy II content. that contained reverse transcriptase activity equal to 6 ng (5 U/μg) of recombinant reverse transcriptase. The cells were washed as previously Exactly 5 μl of normalized Hirt lysate or 10 μl of endogenous reverse transcription reactions were assayed directly for HIV-1 DNA by 30-35 described and cultured in RPMI 1640 supplemented with 10% FBS, 1% penicillin-streptomycin, 1% glutamine (Gibco-BRL) and 30 U of cycles of 'hot' PCR as previously described. Oligonucleotides were used to detect SF2 LTR DNA that amplified (i) an 87 bp DNA fragment that interleukin-2 (BTI, Inc.). The cells were sampled every 3 days, and either split 1:2 or supplemented with culture media as needed.
contained R ജU5 sequence between ϩ96 and ϩ118 (5Ј-CAAGTA-GTGTGTGCCCGTCTGTT-3Ј, sense) and ϩ182 and ϩ158 (5Ј-Approximately 10 7 HeLa, HeLa/CD4 and HeLa/CD4/Tat cells were incubated with DNase I-treated viral supernatants produced from 293 CTGCTAGAGATTTTTCCACACTGAC-3Ј, antisense); (ii) a 111 bp DNA fragment that contained R ജU3 sequences between -49 and -30 cells expressing either wild-type HIV-1, Δtat or Δtat complemented with wild-type tat viral-containing activity equal to 15 ng of reverse (5Ј-TGGCGTGCCCTCAGATGCTG-3Ј, sense) and between ϩ62 and ϩ42 (5Ј-AAGCAGTGGGTTCCCTAGTTAG-3Ј, antisense) and (iii) a transcriptase (5 U/μg) or heat-inactivated viruses for 2 h at 37°C with constant shaking. Cells were washed three times with media. At 24 h 147 bp DNA fragment that contained the R ജ5Ј-untranslated gag sequences between ϩ96 and ϩ118 (5Ј-CAAGTAGTGTG-TGCCCGTpost-infection, cells were harvested and Hirt lysates were prepared. The DNA amounts were normalized using PCR with the cyt-oxy II gene as CTGTT-3Ј, sense) and between ϩ242 and ϩ219 (5Ј-CCTGCGTCGAG-AGAGCTCCTCTGG-3Ј, antisense). All PCR reactions were subject to an internal control, and PCR analysis was performed to analyze HIV-1 reverse transcription products. electrophoresis in polyacrylamide gels as described. Quantitative RT-PCR was performed using HIV-1 virion-associated RNA isolated from pelleted virus particles. DNase I-treated virus stocks Endogenous reverse transcription assay Virus stocks prepared from 293 cell lines expressing either HIV-1 wildfor either the wild-type or Δtat mutant viruses were subjected to centrifugation at 22 000 g for 90 min and resuspended in 1ϫ PBS/ type, Δtat or Δtat complemented with either wild-type tat or the tat mutants Δcys, Δ53 and Δ60 were assayed for reverse transcriptase BSA. The viral suspensions were assayed for p24 antigen and reverse transcriptase activity. Exactly 100 ng of p24 antigen were suspended in activity (Boehringer Mannheim). For each endogenous reverse transcription reaction, 150 μl of viral supernatants containing reverse transcriptase Trizol reagent (Gibco-BRL) according to the manufacturer's recommendations. During the purification, an in vitro synthesized HIV-1 RNA activity equivalent to 20 pg of recombinant reverse transcriptase were supplemented with 10 mM MgCl 2 and 100 U of DNase I (Worthington (I.C. RNA) was added to monitor RNA recovery and in vitro reverse transcription efficiency (Harrich et al., 1996) . Nucleic acids were Biochemical Corp.) then incubated at 30°C for 20 min. As a control for DNase I activity, 10 6 copies of an HIV-1 LTR plasmid was added to the precipitated overnight (-20°C) and recovered by centrifugation at 15 000 g at 2°C for 60 min. A visible pellet was washed with 70% viral supernatant. Next, 50 μl of the treated supernatants were added to 200 μl of stop solution (10 mM Tris pH 8.0, 10 mM EDTA, 20 μg/ml ethanol, centrifuged as before and the pellet was resuspended in 30 μl of PCR TE (10 mM Tris pH 7.8, 0.1 mM EDTA). Duplicate reactions sheared herring sperm DNA, 50 μg/ml proteinase K), then incubated at 50 and 95°C for 10 min at each temperature. The remaining supernatants that contained 5 μl of each viral RNA, 50 ng of the oligonucleotide primer (ϩ242/ϩ219) (5Ј-CCTGCGTCGAGAGAGCTCCTCTGG-3Ј, antisense) were supplemented with either 12 μM dNTP (3 μM each dATP, dCTP, dGTP and dTTP) or 12 μM dNTPs minus dTTP and incubated at 37°C and 5 ml of dimethylsulfoxide were incubated at 65°C for 10 min. In vitro reverse transcription reactions were performed in the presence and for 60 min. The reactions was terminated with 400 μl of stop solution then incubated at 50 and 95°C for 10 min at each temperature. Assays absence of M-MLV reverse transcriptase (Gibco-BRL) with buffers provided by the manufacturer plus 0.1 mM dNTPs at 37°C for 30 min. transcription primers other than the natural tRNA Lys3 . J. Virol., 69, First, each reverse transcription reaction was serially diluted in 5-fold 3090-3097. increments and assayed for the internal control RNA (I.C. RNA) by Dayton,A.I., Sodroski,J.G., Rosen,C.A., Goh,W.C. and Haseltine,W.A. 'hot' PCR for 30 cycles as previously described, using oligonucleotide (1986) The trans-activator gene of the human T cell lymphotropic primers made to the polylinker region of the I.C. RNA (5Ј-virus type III is required for replication. Cell, 44, 941-947. CTTGCATGCCTGCAGGTCGACT-3Ј, forward) and HIV-1 sequences Dingwall,C., Ernberg,I., Gait,M.J., Green,S.M., Heaphy,S., Karn,J., from ϩ62 to ϩ42 (5Ј-AAGCAGTGGGTTCCCTAGTTAG-3Ј, antisense) Lowe,A.D., Singh,M. and Skinner,M.A. (1990) HIV-1 Tat protein (Harrich et al., 1990) . The reverse transcription reactions were normalized stimulates transcription by binding to a U-rich bulge in the stem of to I.C. RNA concentrations and amplified by 'hot' PCR for 30 cycles the TAR RNA structure. EMBO J., 9, 4145-4153. as described using the HIV-1-specific oligonucleotide primers (ϩ96/ Feinberg,M.B., Baltimore,D. and Frankel,A.D. (1991) The role of Tat ϩ118) (5Ј-CAAGTAGTGTGTGCCCGTCTGTT-3Ј, sense) and a primer in the human immunodeficiency virus life cycle indicates a primary nested to the cDNA first strand primer (ϩ236/ϩ214) (5Ј-CGAGAGeffect on transcriptional elongation. Proc. Natl Acad. Sci. USA, 88, AGCTCCTCTGGTTCTAC-3Ј-antisense). The PCR products were separ-4045-4049. ated on a 6% polyacrylamide gel system in 1ϫ TBE, dried and quantified Feng,S. and Holland,E.C. (1988) HIV-1 Tat trans-activation requires the on a Molecular Dynamics PhosphoImager.
loop sequence within TAR. Nature, 334, 165-167. Fisher,A.G. et al. (1986) The trans-activator gene of HTLV-III is essential for virus replication. Nature, 320, 367-371.
